[VXUS] Vanguard Total International Stock ETF

Overview

Type of security: Fund

Tags: Blend, Broad ex-US, Broad market, Country, Equity, ETF, ex-US, Index Based, International, Large-cap, Not Inversed, Regional, Stocks, U.S., Unleveraged

The data is delayed by 15 minutes.

 

Price: 45.57 Change: 0.13 (0.29%)
Ext. hours: Change: 0 (0%)

chart VXUS

Refresh chart

Strongest Trends Summary For VXUS

VXUS is in the medium-term down -12% below S&P in 2 years. In the long-term down -20% below S&P in 4 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in developed and emerging markets, excluding the United States. The fund employs an indexing investment approach designed to track the performance of the FTSE Global All Cap ex U.S. Index, a free-float-adjusted market-capitalization-weighted index designed to measure equity market performance of companies located in developed and emerging markets, excluding the United States. The index includes more than 5,330 stocks of companies located in 45 countries.

See how to gain 20% in 14 sec with TrendsInvesting

Technical Data
High 52 week55.21 Low 52 week45.57 Last close50.38 Last change-0.77%
RSI28.7 Average true range0.61 Beta1.02 Volume671.76 K
Simple moving average 20 days-2.88% Simple moving average 50 days-3.01% Simple moving average 200 days-0.57%
Performance Data
Performance Week-1.1% Performance Month-4.64% Performance Quart-1.96% Performance Half0.76%
Performance Year-6.98% Performance Year-to-date7.04% Volatility daily0.81% Volatility weekly1.81%
Volatility monthly3.72% Volatility yearly12.87% Relative Volume369.47% Average Volume1.43 M
New High New Low
Funds Characteristics
30-day SEC yield Average market capitalization Average weighted market capitalization Forward P/E
Gross expense ratio Index dividend yield Median market cap26 B Number of holdings5689
Price to Book Value 1.6 Price to Earnings16.7 Total expense ratio0.14% Total net assets2.64 M
Weighted market capitalization

Info

Characteristics:
NAME VALUE
Total Expense Ratio0,14
Total Net Assets2,644 million
Fund Total Net Assets120,435 million
Number Of Holdings5689
Median Market Cap26.4b
P/E Ratio16,7
P/Bv Ratio1,6
Top Countries:
NAME VALUE
United Kingdom15,3
Japan14,8
Canada7,1
France6,6
Germany6,4
Switzerland6,2
Australia5,6
China3,6
Korea3,2
Taiwan2,8
Top Holdings:
NAME VALUE
Nestle Sa1,1
Royal Dutch Shell Plc1,1
Roche Holding Ag1
Novartis Ag0,9
Hsbc Holdings Plc0,9
Bhp Billiton Ltd.0,8
Toyota Motor Corp.0,7
Bp Plc0,7
Samsung Electronics Co. Ltd.0,6
Total Sa0,6

News

2020-06-02 22:44:20 | Keep a Delicate Balance With Foreign Stocks

2020-04-30 00:00:00 | COVID Crash: ETFs That Worked

2020-04-03 10:58:56 | 27 Solid Ways to Build Your Wealth

2020-03-31 12:35:00 | Here’s why owning non-U.S. stocks is causing your portfolio a world of hurt

2020-03-16 00:00:00 | Why High Quality Bond ETFs Failed Us

2020-03-03 00:00:00 | Market Turmoil Pits Instinct Vs. Logic

2020-02-25 08:35:30 | Maybe Not The ETF You Want Right Now, But Don't Forget About It

2020-02-13 12:43:00 | The lessons of Vanguard’s Jack Bogle have helped countless investors — but his picks could be improved

2020-02-05 00:00:00 | All-Equity ETF Portfolio Doesn’t Add Up

2020-01-16 00:00:00 | Vanguard’s Winds Of Change Quite Chilly

2020-01-13 08:00:07 | Reach 'Financial Success' With Just 3 Investments, Top Advisor Says

2020-01-06 13:15:08 | 3 International Vanguard ETFs With Newly Lower Fees

2019-12-31 14:30:07 | Most Loved/Hated ETFs of the Fourth Quarter

2019-12-17 12:55:07 | 11 Foreign Stocks With The Lowest Earnings Multiples

2019-10-07 10:45:00 | 3 Keys To Int’l Stocks Beating US

2019-08-01 23:29:51 | Navigate the Universe of ETFs

2019-05-24 16:30:00 | Converting Vanguard Mutual Funds To ETFs

2019-05-24 08:00:17 | Vanguard Total International Stock ETF: Get Broad Exposure Overseas

2019-04-30 13:19:01 | Vanguard Cuts Expense Ratios on 21 Ultra Low-Cost ETFs

2019-03-27 07:00:00 | Build a Strong Foundation for Long-Term Investment Success

2019-03-04 06:00:00 | Vanguard's Latest Fee Cuts in 4 Charts

2019-02-27 11:00:00 | Vanguard Launches Another Salvo in the Ongoing ETF Fee War

2019-02-27 08:00:01 | Vanguard Intensifies ETF Fee War Again

2019-02-26 16:43:00 | Vanguard Cuts ETF Fees

2019-02-04 14:35:12 | The Kip ETF 20: The 20 Best Cheap ETFs You Can Buy

2019-01-23 07:00:00 | The Trouble With Market-Cap Weighting

2019-01-16 14:57:30 | 7 Best ETFs for Novice Investors

2019-01-15 15:04:53 | The 19 Best ETFs for a Prosperous 2019

2018-12-24 11:51:56 | International Diversification On The Cheap

2018-12-24 10:54:34 | A Big, Broad, Cheap International ETF

2018-12-21 07:00:00 | This Is One of the Broadest Foreign-Stock Funds Available

2018-10-26 07:00:00 | Cheap, Diversified Exposure to Foreign Developed Markets

2018-10-01 08:00:03 | Long-Term Retirement Investment Strategies With ETFs

2018-09-12 11:05:00 | Can 2 ETFs Provide All the Diversification You Need?

2018-08-29 10:48:15 | Vanguard ETF ‘VTI’ Hits $100 Billion in Assets

2018-06-21 15:12:18 | Build a Total Portfolio With Just 5 Vanguard ETFs

2018-06-12 10:47:54 | Weekly Research Briefing: Risk in Traveling

2018-04-20 06:00:00 | 3 ETF Retirement Bucket Portfolios for Taxable Accounts

2018-04-20 06:00:00 | 3 ETF Retirement Saver Portfolios for Taxable Accounts

2018-04-03 11:24:00 | 3 Low-Cost International Funds to Last a Lifetime

2018-02-13 17:45:02 | Why Investors Should Monitor Geopolitical Risks

2018-02-09 10:31:00 | Live Well While The Market Tanks

2018-02-09 07:34:41 | A Deeper Look at Valeant Pharmaceuticals’ Recent Financial Performance

2018-02-06 09:46:07 | What’s behind the Stock Market Fall?

2018-02-06 07:32:30 | Analysts’ Recommendations for Novartis after Its 4Q17 Earnings

2018-01-31 09:03:32 | GlaxoSmithKline Projects Tough Environment for Triumeq and Tivicay

2018-01-25 16:04:03 | What Analysts Recommend for GlaxoSmithKline in January 2018

2018-01-23 15:39:43 | How Is Novartis’s Kymriah Positioned for 2018?

2018-01-17 07:30:37 | Teva Pharmaceutical: Still Focused on New Product Launches

2018-01-16 09:00:34 | How Teva Pharmaceutical Plans to Improve Financial Profile